-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Protara Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
- Protara Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.06M, a 34.2% decline year-over-year.
- Protara Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $5.19M, a 14.4% decline year-over-year.
- Protara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.09M, a 8.91% decline from 2022.
- Protara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.69M.
- Protara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $943K, a 72.5% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)